Deferiprone, efficacy and safety
The Indian Journal of Pediatrics2004Vol. 71(3), pp. 213–216
Citations Over TimeTop 22% of 2004 papers
Related Papers
- → Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count(2013)18 cited
- → Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis(2013)16 cited
- → Deferiprone‐associated myelotoxicity(1994)71 cited
- → Deferiprone-Induced Agranulocytosis(1997)9 cited
- Effectiveness of Deferiprone (GPO-L-ONE®) Chelation Therapy in Adult Thalassemia Patients with Iron Overload(2012)